The immune role of Bcl2 antibodies in Syrian breast cancer pateints after treatment


Abstract in English

recurrence is a major problem which affects 40% of Breast cancer patients . Bcl2 is an antiapoptotic protein which is implicated in many cases of cancer development and cancer resistance to therapy. Aim of study : investigate the role of Bcl2 in recurrence in Breast cancer patients

References used

IARC: international Agency for Research on cancer: World cancer Report 2012 Breast cancer Estimated Incidence

Download